BC Cancer, Vancouver: Cancer Care and Clinical Trials

BC Cancer’s origins date to the late 1930s, and it now operates within British Columbia’s Provincial Health Services Authority. Its remit combines cancer care, prevention, screening and research. The Vancouver centre forms part of this provincial service rather than operating as a separate international cancer hospital.

The established six-centre network includes Vancouver, Victoria, Surrey, Abbotsford, Kelowna and Prince George. These regional centres work with hospitals, community services and other healthcare professionals. This structure supports care across a geographically large province, but individual investigations, procedures and specialist appointments may occur at different sites. Patients should confirm which location would be responsible for each part of their care.

Notable organisational activities include population-based screening programmes, cancer research and genomic science. Canada’s Michael Smith Genome Sciences Centre contributes sequencing and computational expertise, while personalised onco-genomics research examines how tumour characteristics might inform treatment decisions. Screening programmes have their own eligibility rules and are distinct from diagnostic assessment for someone who already has symptoms or a cancer diagnosis.

BC Cancer’s programmes include breast, lung, prostate and colorectal cancers. Care planning depends on the tumour’s precise classification, stage, molecular features and the patient’s general health. For breast and prostate cancers, pathways may combine local treatments with hormone-directed or other systemic therapies. Lung and colorectal cancer assessment may include biomarker testing when results could change treatment recommendations.

Blood cancers are also within the wider cancer-care system, but the appropriate service depends on the diagnosis. Leukaemia, lymphoma and myeloma can require different specialist teams and hospital resources. Patients considering intensive treatment, transplantation or cellular therapy should ask specifically which institution provides the service and whether international referrals are accepted. A listed cancer speciality does not mean every treatment for that cancer is offered at the Vancouver centre.

Systemic treatment options include chemotherapy, hormone therapy, immunotherapy and targeted therapy where clinically appropriate. Selection depends on evidence for the cancer subtype, previous treatment, biomarkers, organ function and potential side effects. A medicine’s availability in Canada does not automatically establish access or funding for an international patient.

Radiation therapy is a core component of BC Cancer’s services. A radiation oncologist determines whether it is suitable and recommends the treatment approach and schedule. Planning scans, preparation appointments and monitoring can extend the overall stay beyond the treatment sessions themselves. Patients should request an individual timetable rather than estimate travel dates from a general treatment description.

Surgery can be part of a BC Cancer-associated treatment pathway, but it is generally delivered through hospital-based surgical teams. Assessment, anaesthesia, admission and postoperative care may therefore involve another institution. International patients should establish who coordinates this pathway and whether separate referrals, acceptance decisions and financial arrangements are required.

Clinical trials may offer access to investigational treatments or new uses of established therapies. Genomic testing may help identify relevant studies, but it can also produce no actionable finding. Research participation is not a substitute for discussing established options, and supportive or palliative care can accompany treatment at any disease stage.

The supplied profile describes around 200 active oncology clinical trials. This is an indicative figure rather than a verified current recruitment count: the total changes as studies open, close or move into follow-up. An active study may not be enrolling new participants, and a network-wide study may not be available in Vancouver. The current portfolio and recruiting locations should be checked directly with BC Cancer.

International patients can ask the relevant clinical team whether any recruiting study matches their diagnosis, biomarkers and treatment history. Eligibility commonly depends on previous therapies, disease measurements, blood tests, organ function and functional status. The study team must also clarify whether non-residents can participate and whether repeated visits or local follow-up are feasible. Consent, screening and a suitable trial place are required; an initial enquiry or promising molecular result does not guarantee enrolment.

Before booking travel, ask BC Cancer which referral route applies to someone living outside Canada and whether the requested service accepts international patients. Submit a concise clinical summary and request confirmation of the receiving team, proposed assessment site and any additional records needed. Public funding for eligible British Columbia residents should not be assumed to extend to visitors. Obtain written clarification of payment responsibility and any insurer authorisation requirements.

Plan for more than the first consultation. Pathology review, repeat imaging, treatment preparation and management of complications may affect the schedule. Ask whether an accompanying caregiver is advisable and how care will be transferred back to your home oncology team. Carry sufficient prescribed medicines and relevant documentation, subject to Canadian entry rules. Choose flexible travel arrangements only after the clinical team has clarified the expected pathway.

Contact details below come from the hospital's own published international patient information.

Location: Vancouver, Canada

Email: No public international e-mail address is published; use the website enquiry form.

Phone: +1 604 877 6000

Website: http://www.bccancer.bc.ca

Languages supported: English, French

Remote second opinion: Not advertised

Always confirm current contact details on the hospital's own website before sending medical records, and never send documents to an address you have not verified.